4887
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

SAWAI GROUP HOLDINGS Co., Ltd. is a holding company that manages the business activities of its subsidiaries, which are engaged in the manufacturing and sales of pharmaceuticals. The group consists of six consolidated subsidiaries, with Sawai Pharmaceutical serving as the primary entity for the production and domestic distribution of medical and general pharmaceuticals to wholesalers, other manufacturers, and medical institutions. Medisa Shinyaku handles the sales of medical drugs and facilitates product transactions between group members, while also outsourcing research and development and manufacturing to Sawai Pharmaceutical. Kaken Seiyaku and Trust Pharmatec are involved in the manufacturing and sales of medical pharmaceuticals, with Trust Pharmatec receiving outsourced R&D and manufacturing services from Sawai Pharmaceutical. FrontAct operates in the manufacturing and sales of medical devices. The group sources active pharmaceutical ingredients from Kaken Seiyaku and manages its operations through a structure of domestic and international subsidiaries.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Drug Manufacturers - Specialty & Generic Homepage sawaigroup.holdings
Sector Healthcare IR page sawaigroup.holdings
Tags
pharmaceutical manufacturing, pharmaceutical distribution, medical devices, active pharmaceutical ingredients, outsourced manufacturing, research and development, Sawai Pharmaceutical, Medisa Shinyaku, Kaken Seiyaku, Trust Pharmatec, FrontAct
Press page sawaigroup.holdings/ir/news

Metrics

Valuation  
Market cap ¥ 191.229B
Market cap (USD) $ 1.2B
P/E 20.07
PEG —
P/BV 1.06
P/S 0.93
P/OCF 18.22
P/FCF -11.05
Dividend yield 3.3%
Turnover / mcap —
Returns  
ROE 5.9%
ROI 3.7%
ROIC 4.5%
Profit margin 5.2%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -6.2%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 36
Quality score -27.8%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014
Revenue 201.676B 189.024B 176.862B 200.344B 193.816B 187.219B 182.537B 184.341B 168.127B 132.428B 123.492B 105.454B 89.824B
Net profit 10.438B 11.969B 13.695B 12.667B -28.269B 12.34B 19.279B 19.376B 10.633B 15.914B 17.156B 14.053B 12.193B
Free cash flow -17.038B 337M -1.5B -14.115B 10.966B 18.858B 24.755B 35.423B — — — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014
Share price 2.228K 1.981K 6.025K 3.647K 4.486K 5.778K — — — — — — —
Price performance 12m 0.12 -0.67 0.65 -0.19 — 0 — — — — — — —

Filed figures

Figure Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Borrowings, current (JPY) — 13.1B 13B 16B 21.5B 14.7B
Borrowings, non-current (JPY) — 53.6B 60.1B 66.8B 69.8B 90.3B
Cash and deposits (JPY) 54.3B 47.7B 33.1B 26.4B 38.8B 29B
Intangible assets (JPY) — 26.3B 27.1B 20.3B 27.2B 29.7B
Right-of-use assets (JPY) — 3.6B 3.08B 3.42B 2.83B 2.9B
Net debt (borrowings + leases - cash) (JPY) — 19B 40.1B 56.5B 52.6B 76B
Cash flow detail
Operating cash flow (JPY) — 34.3B 13B 23.1B 27.9B 7.43B
Purchases of property, plant and equipment (JPY) — -14.5B -20.7B -17.9B -20.6B -13.4B
Purchases of intangible assets (JPY) — -8.83B -6.41B -6.73B -6.95B -11.1B
Change in inventories (cash effect) (JPY) — -5.63B -14.9B -9.17B -9.96B -7.56B
Dividends paid (cash effect) (JPY) — -5.69B -5.69B -5.69B -6.07B -6.24B
Share buybacks (cash effect) (JPY) — — — 0.00 -33.3B —
Interest paid (cash effect) (JPY) — -512M -410M -484M -754M -1.14B
Income taxes paid (cash effect) (JPY) — -6.01B -7.47B -5.83B -1.25B -1.75B
Free cash flow (OCF - PPE - intangibles) (JPY) — 11B -14.1B -1.5B 337M -17B
Income detail
Research and development expense (JPY) — 24.4B 16.1B 12.2B 12.6B 12.4B
Total comprehensive income (JPY) — -35B 18.2B 13.3B 407M 10.9B
Comprehensive income to owners (JPY) — -22.6B 17.1B 16.7B 407M 10.9B
Segments
Japan · Segment revenue (JPY) — 164B 164B — — —
↳ YoY growth -0.1%
Japan · Segment operating income (JPY) — 32.4B 16.1B — — —
USA · Segment revenue (JPY) — 30B 36.6B — — —
↳ YoY growth +22.2%
USA · Segment operating income (JPY) — -68.2B 930M — — —
Reported Aug 5, 2021 Jun 24, 2022 Jun 27, 2023 Jun 24, 2025 Jun 24, 2025 Jun 24, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

半期報告書-第6期(2026/04/01-2027/03/31) Bull 0 Bear 2 Results

Prompts

SAWAI GROUP HOLDINGS Co., Ltd. (ticker 4887), listed in Japan.

Company History

Date Change Detail
— Continues Continues 4555 (EDINET code E00976) as 4887: the same business renamed or reorganised. Its figures from before are this company's.

ETFs Holding SAWAI GROUP HOLDINGS Co., Ltd.

ETF Weight in ETF Shares Market value As of
ADVE 0.27% 2,400 $ 24.882K Jun 30, 2026
DFIS 0.05% 302,100 $ 3.138M Nov 12, 2026
DISV 0.02% 92,900 $ 965.021K Nov 12, 2026
DXIV 0.02% 3,600 $ 37.396K Nov 12, 2026
AVDV 0.01% 100,200 $ 1.017M Nov 16, 2026
AVDS 0.01% 4,900 $ 49.745K Nov 16, 2026
DFIC 0.01% 133,200 $ 1.384M Nov 12, 2026
DFAX 0.01% 77,100 $ 800.895K Nov 12, 2026
DFAI 0.00% 76,400 $ 793.624K Nov 12, 2026

Securities

Ticker Type Class Market Exchange Last price Price date
4887 canonical Common share — JP tsej 1,653.00 JPY 2026-11-12
4555 delisted Common share — JP tsej — —